2001Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical PsychopharmacologyRequires access

Use of antidepressants in smoking cessation treatment: Bupropion -

Cüneyt Evren

Open publisher page 1 citations

Abstract

Smoking remains to be the major preventable cause of early mortality and morbidity. At least 70% of the smokers who quit smoking don't succeed despite the use of the best nicotine replacement treatment (NRT) with behavior treatment. Findings that there is an increased prevalence of depression among smokers and that smokers with depression, have greater difficulty quitting than those without depression led to the investigation of antidepressants as aids for smoking cessation. The aim of this review is to explore the research literature for treating nicotine dependence with antidepressants. Bupropion, which seems to be effective in smoking cessation treatment, reduces withdrawal symptoms and weight gain, which occurs after quiting smoking, and throughout out the treatment. With these properties, bupropion comes in view as a useful treatment intervention in smoking cessation.

About this research paper

What this paper is about

Smoking remains to be the major preventable cause of early mortality and morbidity. At least 70% of the smokers who quit smoking don't succeed despite the use of the best nicotine replacement treatment (NRT) with behavior treatment. Findings that there is an increased prevalence of depression among smokers and that smokers with depression, have greater difficulty quitting than those without depression led to the investigation of antidepressants as aids for smoking cessation. The aim of this review is to explore the research literature for treating nicotine dependence with antidepressants. Bupropion, which seems to be effective in smoking cessation treatment, reduces withdrawal symptoms and weight gain, which occurs after quiting smoking, and throughout out the treatment. With these properties, bupropion comes in view as a useful treatment intervention in smoking cessation.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Smoking remains to be the major preventable cause of early mortality and morbidity. At least 70% of the smokers who quit smoking don't succeed despite the use of the best nicotine replacement treatment (NRT) with behavior treatment. Findings that there is an increased prevalence of depression among smokers and that smokers with depression, have greater difficulty quitting than those without depression led to the investigation of antidepressants as aids for smoking cessation. The aim of this review is to explore the research literature for treating nicotine dependence with antidepressants. Bupropion, which seems to be effective in smoking cessation treatment, reduces withdrawal symptoms and weight gain, which occurs after quiting smoking, and throughout out the treatment. With these properties, bupropion comes in view as a useful treatment intervention in smoking cessation.

Key concepts: Bupropion, Smoking cessation, Medicine, Nicotine replacement therapy, Depression (economics), Nicotine, Psychiatry, Nicotine withdrawal

Related papers

Back to paper searchBrowse research topicsOriginal source
Use of antidepressants in smoking cessation treatment: Bupropion - — Research Paper | ScholarLens